Edwards Lifesciences (EW) Other Non Operating Income (2015 - 2026)

Edwards Lifesciences has reported Other Non Operating Income for 12 years, with the latest figure at $16.6 million in Q2 2026.

• On a quarterly basis, Other Non Operating Income rose 1376.92% year-over-year to $16.6 million in Q2 2026; TTM through Jun 2026 was $94.0 million, a 50.4% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, down 89.55% from the prior year.
• Other Non Operating Income was $16.6 million for Q2 2026 at Edwards Lifesciences, down from $71.5 million in the prior quarter.
• The five-year high for Other Non Operating Income was $71.5 million in Q1 2026, with the low at -$3.3 million in Q1 2022.
• Average Other Non Operating Income over 5 years is $10.2 million, with a median of $3.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income sank 242.86% in 2022, then soared 2650.0% in 2026.
• Over 5 years, Other Non Operating Income stood at $5.8 million in 2022, then tumbled by 37.93% to $3.6 million in 2023, then surged by 825.0% to $33.3 million in 2024, then slumped by 90.39% to $3.2 million in 2025, then soared by 418.75% to $16.6 million in 2026.
• The last three Other Non Operating Income figures came in at $16.6 million (Q2 2026), $71.5 million (Q1 2026), and $3.2 million (Q4 2025), per Business Quant data.